Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 1/20 | 0.31 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23837348 | 0.87 | CA12 (0.30) | CA12CA1CA2CA7CA9 | |
| SCHEMBL17347653 | 0.87 | MTNR1A (0.33) | MTNR1AMTNR1BCA12CA1CA2 | |
| SCHEMBL23837357 | 0.86 | — | — | |
| SCHEMBL17347791 | 0.78 | MTNR1A (0.30) | MTNR1AMTNR1BCA12CA1CA2 | |
| SCHEMBL23130239 | 0.78 | MTNR1A (0.30) | MTNR1AMTNR1BCA12CA1CA2 | |
| SCHEMBL17347778 | 0.78 | — | — | |
| SCHEMBL17347686 | 0.76 | CA12 (0.33) | MTNR1AMTNR1BCA12CA1CA2 | |
| SCHEMBL23130283 | 0.76 | CA12 (0.33) | MTNR1AMTNR1BCA12CA1CA2 | |
| SCHEMBL23837408 | 0.74 | KDM4E (0.34) | — | |
| SCHEMBL23130232 | 0.73 | MTNR1A (0.36) | MTNR1AMTNR1BCA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3882252-A1 | BETA-LACTAMASE INHIBITORS | Venatorx Pharmaceuticals, Inc. (US) | 2021-09-22 | — | — | EP | disclosed |